Delayed Nyse  -  04:03 2022-08-18 pm EDT
48.58 USD   -1.40%
08/17GSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
08/17Moderna - Evidation Enables First of Its Kind Moderna Study to Track COVID Vaccine Response in Real Life
08/17GSK shares ease after plaintiff in first Zantac lawsuit drops case
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Shots for tots: COVID vaccinations start for little US kids

06/22/2022 | 10:35am EDT

Little Fletcher Pack woke up Monday morning and asked: “Is today vaccine day?”

For the 3-year-old from Lexington, South Carolina, the answer was yes.

The nation’s infants, toddlers and preschoolers are finally getting their chance at COVID-19 vaccination as the U.S. rolls out shots for tots this week. Shipments arrived in some locations over the weekend and some spots, including a Walgreens in South Carolina and another in New York City, opened up appointments for Monday.

Fletcher's mother said that once her son is fully vaccinated, he can finally go bowling and visit the nearby children’s museum.

“He’s never really played with another kid inside before,” McKenzie Pack said. “This will be a really big change for our family.”

She began seeking an appointment last week as U.S. regulators took steps to OK the vaccines for kids 6 months to 5 years old.

“It’s just relief,” said Pack. "With this vaccine, that’ll be his best shot at going back to normal and having a normal childhood.”

The Food and Drug Administration greenlighted the Moderna and Pfizer kid shot s on Friday and the Centers for Disease Control and Prevention recommended them Saturday. In the U.S., COVID-19 vaccines were first tested and given in late 2020 to health care workers and older adults. Teens and school-age kids were added last year.

“This is certainly an exciting moment in what has become a very long campaign to vaccinate people against COVID-19,"said Dr. Matthew Harris, an emergency room pediatrician at Northwell Cohen Children’s Medical Center in New York.

Many parents have been anxiously awaiting the rollout, and Harris said shots for his own 9-month-old are a “matter of when, not if.’’

Roughly 18 million youngsters under 5 are eligible.

“It’s just a huge step toward normalcy,’’ said Dr. Debra Langlois, pediatrician at University of Michigan Health C.S. Mott Children’s Hospital.

“We’re two-plus years into this pandemic and there’s things that my 4-year-old has never been able to do,’’ Langlois said.

The family skipped a trip to Disneyland and a popular Michigan vacation island because the ferry ride to Mackinac Island would mean mingling with unmasked passengers.

President Joe Biden, public health authorities and pediatricians hailed the moment. But they also acknowledged that getting some parents on board may be a challenge given disappointing vaccination rates — about 30% — in school-age kids.

The American Academy of Pediatrics and American Medical Association were among physician groups that encouraged doctors and families to get young children vaccinated.

The CDC advises vaccination even for those who already had COVID-19 to protect against reinfection, and says it is OK to get other vaccines at the same time. For the littlest kids, there's Pfizer’s three-shot series or Moderna’s two shots.

In New York’s largely Latino neighborhood of Washington Heights, Dr. Juan Tapia Mendoza’s clinic has ordered 300 doses of the tot-sized vaccines. He said he needs educational materials that directly address misinformation spreading among parents.

His approach will be to tell parents “if they were my kids, I would vaccinate them."

"Because the virus is still around. A lot of people are still dying because of coronavirus Kids do get infected and some kids get severely affected and nobody wants to see a child very sick.”

Some hospitals planned vaccination events later this week. Chicago is among locations that offer COVID-19 shots in people’s homes and planned to open registration this week for home appointments for infants and other young children, said Maribel Chavez-Torres, a deputy commission for the city’s Department of Public Health.

Dr. Pam Zeitlin, director of pediatric medicine at National Jewish Health in Denver, recommends parents get their kids vaccinated as soon as possible.

“Some parents are afraid that the younger the child, the more vulnerable they might be to vaccine side effects,’’ Zeitlin said, but that’s not what Pfizer and Moderna studies found. Side effects were similar to what is seen with other childhood vaccines — fever, irritability and fatigue.

This story was first published on June 20, 2022. It was updated on June 22, 2022 to correct the last name of Dr. Pam Zeitlin, not Zeitland.

AP Medical Writer Carla K. Johnson contributed.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
MODERNA, INC. -5.06% 150 Delayed Quote.-40.94%
PFIZER, INC. -1.40% 48.58 Delayed Quote.-17.73%
All news about PFIZER, INC.
08/17GSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
08/17Moderna - Evidation Enables First of Its Kind Moderna Study to Track COVID Vaccine Resp..
08/17GSK shares ease after plaintiff in first Zantac lawsuit drops case
08/17GSK Says First US Plaintiff to Drop Zantac Case
08/16Plaintiff in first Zantac lawsuit set for trial drops case
08/16Ambrx Biopharma Names Kate Hermans Interim CEO
08/16PFIZER : Statement from Pfizer Chairman and CEO Albert Bourla on Testing Positive for COVI..
08/16Pfizer Inc. - Statement from Pfizer Chairman and CEO Albert Bourla on Testing Positive ..
08/16Digital innovations and congress coverage led to an increase in all hub users
08/15Pfizer CEO tests positive for COVID-19, has mild symptoms
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 102 B - -
Net income 2022 32 675 M - -
Net cash 2022 11 522 M - -
P/E ratio 2022 8,62x
Yield 2022 3,34%
Capitalization 273 B 273 B -
EV / Sales 2022 2,57x
EV / Sales 2023 3,25x
Nbr of Employees 79 000
Free-Float 59,0%
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 48,58 $
Average target price 56,53 $
Spread / Average Target 16,4%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-17.73%276 521
JOHNSON & JOHNSON-2.51%440 598
ROCHE HOLDING AG-16.47%273 077
ABBVIE INC.4.35%250 080
NOVO NORDISK A/S5.17%239 447